Wire Stories
-
499Global Phase 3 Trial of BeiGene�s PD-1 Inhibitor, Tislelizumab, in Combination with Chemotherapy Meets Primary Endpoint in First-Line Advanced Esophageal Squamous Cell Carcinoma
Statistically significant and clinically meaningful improvement in overall survival achieved for tislelizumab and chemotherapy compared to placebo and chemotherapy Safety profile for...
-
517
UMC Reports First Quarter 2022 Results
12i P3 Singapore expansion plan addresses long term structural demand in 22/28nm First Quarter 2022 Overview1: Revenue: NT$63.42 billion (US$2.22 billion) Gross...
-
534
MassMutual Ventures Announces New USD 300 Million Fund for Europe and Asia-Pacific
BOSTON & LONDON & SINGAPORE–(BUSINESS WIRE)–MassMutual Ventures (MMV) announced today that its Asia-Pacific (APAC) and Europe team has launched a new fund...
-
534
�XPeng Signs Strategic Cooperation Agreement with Agricultural Bank of China, Securing RMB7.5 Billion Credit Facilities
GUANGZHOU, China–(BUSINESS WIRE)–XPeng Inc. (�XPeng� or the �Company�, NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle company, today announced...
-
590
Enevate Joins Andretti Autosport�s Partnership Portfolio for the Honda Indy Grand Prix of Alabama
Andretti Autosport and Enevate align in each company�s quest to further sustainability solutions Enevate will be featured on the No. 28 driven...
-
641
NTT Named a Leader in the 2022 Gartner� Magic Quadrant� for Network Services, Global
Positioned Highest for �Completeness of Vision� and �Ability to Execute� in 2022 NTT recognized as a Magic Quadrant Leader for the 9th...
-
888
Erdenes Tavantolgoi JSC (ETT) Holds its Annual General Meeting and Vows to Create 21,000 Jobs By 2025.
ULAANBAATAR, Mongolia–(BUSINESS WIRE)–The Annual General Meeting of Erdenes Tavantolgoi JSC, one of the largest mining companies in Mongolia, was held on April...
-
531
Renesas Announces Acquisition of and Tender Offer for Own Shares
TOKYO–(BUSINESS WIRE)–Renesas Electronics Corporation (�Renesas�, TSE:6723), a premier supplier of advanced semiconductor solutions, today announced that it has resolved at the Meeting...
-
531
Renesas Reports Financial Results for the First Quarter Ended March 31, 2022
TOKYO–(BUSINESS WIRE)–Renesas Electronics Corporation (TSE:6723) today announced consolidated financial results in accordance with IFRS for the three months ended March 31, 2022....
-
519
iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement
PixoTech� licensing shifted in as iXensor’s new growth engine to meet self-testing strong demand in the post-pandemic era TAIPEI, Taiwan & OSAKA,...
